imatinib mesylate has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abd Elkader, AS; Abdel Hammed, MR; Mohamed, NM; Nafady, HA | 1 |
| Bose, SK; Di Bisceglie, AM; Kwon, YC; Meyer, K; Ray, R; Ray, RB; Steele, R | 1 |
| Cambazard, F; Chraïbi, R; Labeille, B; Perrot, JL | 1 |
3 other study(ies) available for imatinib mesylate and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Kinetic of liver enzymes and serum electrolytes in HCV, HBV, and HIV negative chronic phase chronic myeloid leukemia patients treated with imatinib or nilotinib.
Topics: Adult; Calcium; Fusion Proteins, bcr-abl; Hepatitis B virus; Hepatitis C; HIV Infections; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Treatment Outcome; Young Adult | 2023 |
Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes.
Topics: Animals; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cyclic S-Oxides; Dasatinib; Epithelial-Mesenchymal Transition; Female; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Imatinib Mesylate; Liver Neoplasms; Mice; Neoplasm Transplantation; Neoplastic Stem Cells; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-kit; RNA, Messenger; Sorafenib; Spheroids, Cellular; STAT3 Transcription Factor; Transplantation, Heterologous; Tumor Cells, Cultured | 2015 |
[Porphyria cutanea tarda in a patient presenting hepatitis C treated with imatinib].
Topics: Benzamides; Hepatitis C; Humans; Imatinib Mesylate; Interferon-alpha; Leukemia, Myeloid, Acute; Male; Middle Aged; Piperazines; Porphyria Cutanea Tarda; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines | 2008 |